ACRIX
Price
$27.36
Change
-$0.61 (-2.18%)
Updated
Jun 23 closing price
Net Assets
1.59B
GAGAX
Price
$37.35
Change
-$0.18 (-0.48%)
Updated
Jun 23 closing price
Net Assets
73.35M
Interact to see
Advertisement

ACRIX vs GAGAX

ACRIX vs GAGAX Comparison Chart in %
View a ticker or compare two or three
VS
ACRIX vs. GAGAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRIX is a Hold and GAGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ACRIX has more cash in the bank: 1.59B vs. GAGAX (73.4M). GAGAX pays higher dividends than ACRIX: GAGAX (2.08) vs ACRIX (0.67). ACRIX was incepted earlier than GAGAX: ACRIX (10 years) vs GAGAX (25 years). GAGAX (1.60) is less costly to investors than ACRIX (1.15). ACRIX is a more actively managed with annual turnover of: 172.00 vs. GAGAX (5.00). GAGAX has a lower initial minimum investment than ACRIX: GAGAX (1000) vs ACRIX (10000000). GAGAX annual gain was more profitable for investors over the last year : 16.80 vs. ACRIX (14.82). GAGAX return over 5 years is better than : 21.39 vs. ACRIX (13.75).
ACRIXGAGAXACRIX / GAGAX
Total Expense Ratio1.150.90128%
Annual Report Gross Expense Ratio1.151.6072%
Fund Existence10 years25 years-
Gain YTD11.0365.126215%
Front LoadN/A6%-
Min. Initial Investment1000000010001,000,000%
Min. Initial Investment IRAN/A250-
Net Assets1.59B73.4M2,162%
Annual Yield % from dividends0.672.0832%
Returns for 1 year14.8216.8088%
Returns for 3 years33.5634.1398%
Returns for 5 years13.7521.3964%
Returns for 10 yearsN/A91.77-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRSVX45.82N/A
N/A
Bridgeway Small-Cap Value
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ESPNX41.07N/A
N/A
Allspring Special Small Cap Value Inst
RCLIX46.17N/A
N/A
T. Rowe Price US Large-Cap Core I
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq